China Pharma Holdings, Inc.

CPHI · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$627$1,424$2,030$4,859
Short-Term Investments$0$0$0$0
Receivables$281$728$464$835
Inventory$2,266$3,733$2,948$3,340
Other Curr. Assets$96$112$522$59
Total Curr. Assets$3,270$5,997$5,965$9,093
Property Plant & Equip (Net)$4,530$6,819$9,608$12,967
Goodwill$0$0$0$0
Intangibles$7,087$3,653$2,212$590
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$11,617$10,472$11,820$13,556
Other Assets$0$0$0$0
Total Assets$14,888$16,469$17,784$22,650
Liabilities
Payables$225$966$667$927
Short-Term Debt$2,200$3,182$8,757$7,194
Tax Payable$595$1,027$1,066$842
Deferred Revenue$162$91$520$210
Other Curr. Liab.$1,835$1,554$1,729$1,341
Total Curr. Liab.$5,017$6,821$12,739$10,513
LT Debt$1,391$1,452$0$5,294
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$731$742$755$824
Other NC Liab.$0$0$0$0
Total NC Liab.$2,122$2,194$755$6,119
Other Liabilities$0$0$0$0
Cap. Leases$39$118$40$129
Total Liabilities$7,140$9,015$13,494$16,632
Equity
Pref Stock$0$0$0$0
Common Stock$33$11$75$47
Retained Earnings-$44,027-$39,290-$36,211-$32,239
AOCI$11,320$11,452$11,573$12,564
Other Equity$40,422$35,282$28,854$25,645
Total Equity$7,748$7,455$4,290$6,018
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$14,888$16,469$17,784$22,650
Net Debt$2,964$3,210$6,727$7,629